 |
HDCN
is divided into a FREE ZONE
and a KEY ZONE. The latter is
open only to paid subscribers.
The FREE ZONE is open to all
who have registered
and contains symposia where sponsorship of a professional society
or company was obtained to defray costs of preparation, storage,
and file transfer charges. Currently the FREE
ZONE symposia on HDCN are as follows:
|
 |
|
|
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD).
Rebecca Schmidt, DO, FACP, FASN and Sharon Senft, RN-C, FNP
(ANNA National Symposium, April, 2008.)
|
|
|
Stabilizing Hemoglobin Levels: What’s New in IV Iron and Anemia Management?
Steven Fishbane, MD; Suzann VanBuskirk, BSN, RN, CNN, and Kristin Larson, RN, ANP, GNP, CNN
(ANNA National Symposium, April, 2008.)
|
|
|
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease
Wajeh Qunibi, MD, FACP and Lynda Szczech, MD, MSCE
(ANNA National Symposium, April, 2008.)
|
|
|
Achieving Control: Optimizing the Management of CKD-Anemia
Allen R. Nissenson, MD; Steven Fishbane, MD; Michael J. Germain, MD; Robert Provenzano, MD
(CME Symposium (Synermed-Penn State), March, 2008.)
|
|
|
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008
Wajeh Qunibi, MD, and Charles Nolan, MD
(CME Symposium (Medical Education Resources), January, 2008.) |
 |
|
|
Medical Crossfire: Managing Phosphorus in CKD -- The Challenge Remains
David Bushinsky, MD (moderator); Geoffrey Block, MD, CCRI; Francisco Llach, MD; Rajnish Mehrotra, MD, FACP, FASN.
(Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007) |
|
|
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions
Gérard M. London, MD (moderator); Craig B. Langman, MD; Markus Ketteler, MD.
(Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007) |
|
|
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction
John C. Burnett, MD; Michael B. Fowler, MBBS, FRCP, FACC; Mihai Gheorghiade, MD.
(Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007) |
|
|
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis
Norbert Lameire, MD (moderator); Pontus B. Persson, MD, PhD; Michael V. Knopp, MD, PhD;
Mark A. Perazella, MD
(Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007) |
|
|
New Developments in Anemia Management in Chronic Kidney Disease
Dr. Adeera Levin, MD (moderator): Cindy Roy, PhD; Anatole Besarab, MD; Richard Amerling, MD, Arnold Berns, MD (discussant).
(Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007) |
|
|
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia
Jeffrey S. Berns, MD, FASN; Robert Provenzano, MD; Lynda Szczech, MD. (Moderator: Jeffrey S. Berns, MD)
(Target audience: Physicians. ASN Renal Week Official Symposium. November, 2007) |
|
|
Chronic Kidney Disease - Mineral Bone Disorder
(Jose A.L. Arruda, MD, FACP; Jennifer L. Snavely, CRNP-BC, MSN, CNN) Target audience: Nurses. ANNA National Symposium, April 2007) |
|
|
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease
Sally Burrows-Hudson, MS, RN, CNN; Carol Headley, DNSc, RN, CNN; Sally Campoy, DNP(c), MS, APRN, BC. (Target audience: Nurses. ANNA National Symposium, April 2007) |
|
|
Achieving and Maintaining a Phosphate Balance in the Patient With CKD.
Terran Mathers, DNS, RN. (Target audience: Nurses. ANNA National Symposium, April 2007) |
|
|
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease.
Jay B. Wish, MD; William M. McClellan, Jr, MD; Richard A Lafayette, MD. (RPA Satellite Symposium, March, 2007). |
|
|
Iron Deficiency Anemia in Various Patient Populations. Iron Management Considerations.
Joanna Hudson, PharmD. (Target audience - Pharmacists. Medical Education Resources. February, 2007). |
 |
|
|
Bone and Mineral Metabolism in CKD: Medical Crossfire.
Hartmut H. Malluche, MD; Stuart M. Sprague, DO; Dennis L. Andress, MD (Moderator: Peter Salgo, MD).
(ASN Renal Week Official Symposium. November, 2006) |
|
|
Fluid Dysregulation: Disturbances and Management
Robert W. Schrier, MD; Arthur Greenberg, MD.
(ASN Renal Week Official Symposium. November, 2006) |
|
|
Managing CMV Infections in Transplantation
Robert S. Gaston, MD; Daniel C. Brennan, MD. (Moderator: David Roth, MD).
(ASN Renal Week Official Symposium. November, 2006) |
|
|
Inflammation in CKD: Biomarkers, Morbidity and Therapy
George A. Kaysen, MD, PhD; Mark J. Sarnak, MD; Peter Stenvinkel, MD, PhD.
(ASN Renal Week Official Symposium. November, 2006) |
|
|
The CKD that Follows Renal Transplantation: How to Best Manage these Patients
Anil Chandraker, MD, and Warren L. Kupin, MD. (Moderator: Gabriel Danovitch, MD).
(ASN Renal Week Official Symposium. November, 2006) |
|
|
The New KDOQI Guidelines for Anemia; A Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Allen R. Nissenson, MD and Daniel W. Coyne, MD. (Moderator: Brian J.G. Pereira, MD).
(ASN Renal Week Official Symposium. November, 2006) |
|
|
Lupus Nephritis: Defining and Treating Renal Flares
Ronald J. Falk, MD and Gerald B. Appel, MD.
(ASN Renal Week Official Symposium. November, 2006) |
|
|
New, Tri-Partite Approach to Anemia
(John W. Adamson, MD; Stephen Fishbane, MD; Ajay K. Singh, MB, FRCP; Moderator: Jay B. Wish, MD.)
(ASN Renal Week Official Symposium. November, 2006) |
|
|
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
(Robert N. Foley, MB; Domenic A. Sica, MD. (Moderator: Patrick S. Parfrey, MD)
(ASN Renal Week Official Symposium. November, 2006) |
|
|
Anemia Management in CKD: Improving Iron Management
(ANNA National Meeting, April, 2006) |
|
|
Evidence-based Anemia Management
(ANNA National Meeting, April, 2006) |
|
|
A Balanced Approach to Anemia Therapy: IV Iron and EPO.
(ANNA National Meeting, April, 2006) |
|
|
Practical Considerations for the Management of Anemia in Nephrology Patients: Searching for an Improved Erythropoietic Treatment.
(RPA Satellite Symposium, Released July, 2006) |
 |
|
|
Resistant Hypertension: Reducing Cardiovascular Events
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
Transplantation: Key Issues for the General Nephrologist
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
Post-Transplant Infections: Updating the General Nephrologist
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
Medical Crossfire: An Expert Panel Debates Key Clinical Issues in Mineral Metabolism and Mortality in CKD.
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
Anemia in Renal Disease: Update and Case Discusion
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
Current Concepts in Neurohormones: Vasopressin and the Kidney
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
The Role of Iron Deficiency in Anemia Management: Key Controversies
(ASN Renal Week 2005 Official Symposium. November, 2005) |
|
|
Anemia and Iron Management: Addressing Challenges and Generating Solutions.
(ANNA Fall Meeting Satellite Symposium - September 25, 2005 ) |
|
|
Complications of Anemia and the CKD Patient
(ANNA CE Satellite Symposium. April, 2005 ) |
|
|
Treating Patients With IV Iron Therapy: Special Considerations
(ANNA CE Satellite Symposium - Las Vegas, Nevada, April 21, 2005) |
|
|
Maximizing Patient Outcomes Through IV Iron Therapy and Appropriate Iron Measures
(A CME Symposium at the Renal Research Institute
7th International Conference on Dialysis: Advances in ESRD 2005; New Orleans, January, 2005.) |
 |
|
|
Caring Through the End: Palliative Care Along the Continuum of CKD
(Mid-Atlantic Renal Coalition, Orlando, FL. December, 2004)
|
|
|
Cardiovascular Disease in CKD: Strategies for Reducing Risk
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
Infections and Renal Complications of Immunosuppression: An Update
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
Emerging Data on Iron Management: Clinical Implications
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
CKD and CHF: the Silent Threat
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
Meeting the K/DOQI Mineral and Bone Guidelines in CKD (Stages 3 and 4): The Essential Role of Vitamin D
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
Patients with CKD: Preventing the Complications of Mineral and Metal Accumulation in a Closed System
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
AA Amyloidosis: Diagnosis and Management
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
Evolving Strategies for Renoprotection: From ACEI to Enzyme Replacement Therapy (ERT)
Fabry's Disease: The Nephrologist Perspective
(ASN Renal Week 2004 Official Symposium.
St. Louis, MO. October, 2004) |
|
|
Towards Better Control in CKD: Improving Anemia Management (target audience: Nurses; free CE) --
(ANNA Fall Clinical Practice Sessions, New Orleans, LA; October,
2004) |
|
|
Secondary Hypertension, including Chronic Kidney Disease
(ASN Board Review Course, San Francisco, August, 2004) |
 |
|
|
Phosphorus-PTH-Bone: Achieving Balance and Avoiding Extraosseous Calcification
(ASN Renal Week, San Diego; November, 2003) |
|
|
Addressing Current Challenges & Clinical Implications In Iron Management
(ASN Renal Week, San Diego; November, 2003) |
|
|
A Novel Approach to Controlling Secondary Hyperparathyroidism (HPT): Targeting the Calcium-Sensing Receptor
(ASN Renal Week, San Diego; November, 2003) |
|
|
Intravenous Iron Management for Pharmacists: Safety, Efficacy, Dosing and Pharmacoeconomic Considerations
(Pharmacist CE Symposium, December, 2003) |
|
|
Vitamin D and the Prevention of Morbidity and Mortality in Dialysis Patients(Four Talks and Discussion)
(ASN Renal Week, San Diego; November, 2003) |
|
|
Viral Diseases and Renal Transplantation(Four Talks and Discussion)
(ASN Renal Week, San Diego; November, 2003) |
|
|
Morbidity & Motality Across the CKD Continuim: Can A Renewed Focus on Anemial Improve Outcomes? (Four Talks and Discussion)
(ASN Renal Week, San Diego; November, 2003) |
|
|
Mycophenolate Mofetil: Emerging Role in Glomerular Disease (Four Talks and Discussion)
(ASN Renal Week, San Diego; November, 2003) |
|
|
Chronic Kidney Disease: Emerging Strategies for Managing the Cardio-Renal Syndrome (Four Talks and Discussion)
(ASN Renal Week, San Diego; November, 2003) |
|
|
Making Sense: A Scientific Approach to IV Iron (Three Talks and Discussion)
(ASN Renal Week, San Diego; November, 2003) |
|
|
Addressing the Ongoing Clinical Debate: Implications of Iron Therapy
(A Kidney Learning (KIS) Program) |
|
|
Best Nursing Practices for Central Venous Hemodialysis Catheters (Three Talks)
(ANNA Satellite Symposium, April, 2003
) |
|
|
Focus on the Future: Realities, Challenges, Solutions
(ANNA National Symposium, April, 2003) |
|
|
Options and Issues in Anemia Management (Four talks)
(ANNA Lunch Symposium, April, 2003) |
|
|
IV Iron: Patients & Professionals in Dialogue: Addressing Concerns of Hemodialysis Patients
(ANNA Breakfast Symposium, Chicago;
April, 2003) |
 |
|
|
Development of Hemodialysis: From Access to Machines
(Dorab Patel Memorial Lecture, October, 2002) |
|
|
Practical Management of Secondary Hyperparathyroidism: From Basic Science to Clinical Medicine
(ASN Official Evening Symposium, Philadelphia, PA.
November, 2002) |
|
|
Improving Outcomes in High-Risk Patients with Hypertension
(ASN Satellite Symposium, Philadelphia, PA.
November, 2002) |
|
|
Current Iron Deficiency in CKD: Challenges/Controversies
(ASN Satellite Symposium, Philadelphia, PA.
November, 2002) |
|
|
Executing Change in the Management of Chronic Kidney Disease
(ASN Official Evening Symposium, Philadelphia, PA.
November, 2002) |
|
|
Modern Approaches to Anemia Management: Current Models for Clinical and Practice Operation Success.
(ASN Satellite Symposium, Philadelphia, PA.
November, 2002) |
|
|
Emerging Standards of Care: Implications of New K/DOQI Guidelines
(ASN Satellite Symposium, Philadelphia, PA.
November, 2002) |
|
|
Iron at the Front Lines: A Practical Approach to IV Iron Management
(ANNA Satellite Symposium, Orlando, FL.
May, 2002) |
|
|
Taking Control of Chronic Kidney Disease: Beyond the Kidney
(ANNA Satellite Symposium, Orlando, FL.
May, 2002) |
|
|
Improving Vascular Access Outcomes Using an Innovative Subcutaneous Access System (3 talks)
(ANNA Satellite Symposium, Orlando, FL.
May, 2002) |
|
|
Caring for the Renal Failure Patient: Optimizing Iron Therapy (3 talks, panel)
(ANNA Satellite Symposium, Orlando, FL.
May, 2002) |
|
|
The Advancement of Clinical Practice in Chronic Kidney Disease
(RPA Satellite Symposium, Washington, DC.
March, 2002) |
 |
|
|
Cardiac Calcification in ESRD: New Information Revealed
(ASN/ISN Satellite Symposium, San Francisco, CA,
October, 2001) |
|
|
Current Implications of Abnormal Bone Pathology: Consequences and Therapy
(ASN/ISN Satellite Symposium, San Francisco, CA,
October, 2001) |
|
|
The Evolution of Chronic Kidney Disease: Defining a Model for Care
(ASN/ISN Evening Symposium, San Francisco, CA,
October, 2001) |
|
|
New Therapies for Anemia Management in CKD: An Interactive Symposium
(ASN/ISN Evening Symposium, San Francisco, CA,
October, 2001) |
|
|
Global Management of Chronic Renal Insufficiency. Practical Issues.
(ASN/ISN Evening Symposium, San Francisco, CA,
October, 2001) |
|
|
Managing Intradialytic Hypotension: A Clinical Challenge.
(ASN/ISN Evening Symposium, San Francisco, CA,
October, 2001) |
|
|
Polycystic Liver in PKD; Pain Management in PKD
(Annual PKD Foundation Meeting, Chicago, IL, June, 2001) |
See
also a list of Slide/Audio
Symposia by Topic
|
KEY
ZONE
The symposia on HDCN where no sponsorship was obtained, or where
sponsorship was obtained but where the symposia have been posted
for more than 1 year, are in the KEY ZONE. Please support HDCN and
obtain a paid subscription to access all of this other content.
|
|
|
|
|